At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,008 enrolled
Drug / intervention
NOACdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-Interventional, Cross-sectional Study to Describe NOACs Management ss in Patients With Non-valvular Atrial Fibrillation (NVAF) in Spain.
In Brief
An observational study evaluating NOAC for Atrial Fibrillation. Completed, enrolled 1,008 participants across 75 sites.
Detailed Summary
The primary objective of the study is to describe the usage of NOACs in patients with NVAF, in the hospital setting, based on the baseline characteristics at the time of first NOAC initiation.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 2017
Enrollment StartNov 2017
Primary CompletionJan 2019
TodayJul 2026
First PostedSep 18, 2017
Enrollment StartNov 29, 2017
Primary CompletionJan 31, 2019
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 8.8 years ago
Interventions
NOACdrug
New Oral Anticoagulant